BCL2 and hepatocellular carcinoma: Hemistepsin A exhibited anti-HCC effect by disrupting MMP, up-regulating p53, p21, cleaved caspase-3 and cleaved PARP and reduced the expressions of cyclin D, CDK6 and Bcl-2.